POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	1h4o	PEROXIREDOXIN 5 (Homo sapiens)	4 / 8	GLY A  46 THR A 147 GLY A  41 LEU A 116	BEZ  A1162 (-3.1A) BEZ  A1162 ( 4.0A) None None	0.85A	22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	1q7l	AMINOACYLASE-1 (Homo sapiens)	4 / 8	HIS A  80 GLY B 347 GLY A 151 ASP A  82	ZN  A1002 ( 3.2A) None None None	0.85A	21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	2can	ORNITHINE AMINOTRANSFERASE (Homo sapiens)	4 / 8	GLY A 297 GLY A  91 LEU A  70 ASP A  80	None	0.81A	24.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	2kxh	POLY(U)-BINDING-SPLI CING FACTOR PUF60 (Homo sapiens)	4 / 8	GLY A 251 LYS A 250 GLY A 253 ASP A 222	None	0.82A	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	3d5e	PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE (Homo sapiens)	4 / 8	GLY A 366 THR A 358 GLY A 373 ASP A 376	None	0.79A	19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	4c2k	3-KETOACYL-COA THIOLASE, MITOCHONDRIAL (Homo sapiens)	4 / 8	GLY A 258 GLY A 256 LEU A 350 ASP A 220	None	0.71A	20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AEG_A_4APA296_1 (CYTOCHROME C PEROXIDASE)	4qn9	N-ACYL-PHOSPHATIDYLE THANOLAMINE-HYDROLYZ ING PHOSPHOLIPASE D (Homo sapiens)	4 / 8	HIS A 343 GLY A 131 GLY A 345 LEU A 349	ZN  A 502 ( 3.6A) None None 3PE  A 503 ( 4.6A)	0.73A	21.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1elv	COMPLEMENT C1S COMPONENT (Homo sapiens)	6 / 6	SER A 612 SER A 617 VAL A 638 TRP A 640 GLY A 641 GLY A 648	None SO4  A2001 ( 2.7A) None None None None	0.38A	30.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1fq3	GRANZYME B (Homo sapiens)	4 / 6	SER A 190 SER A 195 VAL A 213 GLY A 216	None SO4  A 800 (-2.4A) None None	0.73A	36.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1fxy	COAGULATION FACTOR XA-TRYPSIN CHIMERA (Homo sapiens)	6 / 6	SER A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	0G6  A   1 (-2.8A) 0G6  A   1 (-1.4A) None None 0G6  A   1 (-3.9A) 0G6  A   1 (-3.3A)	0.35A	55.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1gvl	KALLIKREIN 6 (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None	0.55A	44.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1h4w	TRYPSIN IVA (Homo sapiens)	6 / 6	SER A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	BEN  A 250 (-2.9A) BEN  A 250 (-3.6A) None None BEN  A 250 (-3.9A) BEN  A 250 (-3.3A)	0.23A	72.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1o5f	SERINE PROTEASE HEPSIN (Homo sapiens)	5 / 6	SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	CR9  H 256 (-1.5A) CR9  H 256 (-4.3A) None CR9  H 256 ( 3.8A) CR9  H 256 (-3.0A)	0.22A	41.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1orf	GRANZYME A (Homo sapiens)	4 / 6	SER A 190 SER A 195 GLY A 216 GLY A 226	0G6  A   1 (-2.9A) 0G6  A   1 (-1.3A) 0G6  A   1 (-3.3A) 0G6  A   1 (-3.5A)	0.28A	35.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1q3x	MANNAN-BINDING LECTIN SERINE PROTEASE 2 (Homo sapiens)	6 / 6	SER A 628 SER A 633 VAL A 653 TRP A 655 GLY A 656 GLY A 667	GOL  A 701 (-3.4A) GOL  A 701 (-3.0A) GOL  A 701 (-4.9A) None GOL  A 701 ( 4.1A) GOL  A 701 ( 4.0A)	0.35A	29.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1zjk	MANNAN-BINDING LECTIN SERINE PROTEASE 2 (Homo sapiens)	5 / 6	SER A 633 VAL A 653 TRP A 655 GLY A 656 GLY A 667	None	0.65A	26.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1zlr	COAGULATION FACTOR XI (Homo sapiens)	4 / 6	SER A 195 TRP A 215 GLY A 216 GLY A 226	368  A 901 (-1.4A) None 368  A 901 (-3.6A) 368  A 901 (-3.5A)	0.19A	39.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2ei8	COAGULATION FACTOR X, HEAVY CHAIN (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	DT8  A 700 ( 3.9A) DT8  A 700 ( 4.1A) DT8  A 700 (-3.9A) DT8  A 700 (-3.5A) DT8  A 700 (-3.5A)	0.35A	38.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2ik8	GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1 SUBUNIT (Homo sapiens)	4 / 6	SER A  44 SER A  47 GLY A 203 GLY A  40	GDP  A 401 (-3.6A) MG  A 356 ( 1.9A) ALF  A 355 (-3.3A) None	0.71A	19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2odp	COMPLEMENT C2 (Homo sapiens)	4 / 6	SER A 659 VAL A 677 TRP A 679 GLY A 680	None	0.30A	17.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2oq5	TRANSMEMBRANE PROTEASE, SERINE 11E (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	BEN  A 245 (-3.3A) None None BEN  A 245 ( 3.8A) BEN  A 245 (-3.4A)	0.20A	37.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2pks	THROMBIN HEAVY CHAIN FRAGMENT (Homo sapiens)	5 / 6	SER C 235 VAL C 255 TRP C 257 GLY C 258 GLY C 268	G44  C 101 (-3.5A) None G44  C 101 (-4.1A) G44  C 101 (-3.3A) G44  C 101 (-3.0A)	0.27A	21.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2psy	KALLIKREIN-5 (Homo sapiens)	6 / 6	SER A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None	0.37A	47.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2q3f	RAS-RELATED GTP-BINDING PROTEIN D (Homo sapiens)	4 / 6	SER A  54 SER A  57 GLY A 101 GLY A  50	GNP  A 401 (-3.5A) MG  A 301 ( 2.1A) GNP  A 401 (-3.2A) None	0.68A	21.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2qy0	COMPLEMENT C1R SUBCOMPONENT (Homo sapiens)	5 / 6	SER B 637 VAL B 657 TRP B 659 GLY B 660 GLY B 668	None	0.22A	32.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2r0l	HEPATOCYTE GROWTH FACTOR ACTIVATOR (Homo sapiens)	4 / 6	SER A 195 TRP A 215 GLY A 216 GLY A 226	None	0.21A	37.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2r2w	PLASMINOGEN ACTIVATOR, UROKINASE (Homo sapiens)	6 / 6	SER U 190 SER U 195 VAL U 213 TRP U 215 GLY U 216 GLY U 226	4PG  U 300 (-2.7A) 4PG  U 300 (-3.5A) None None 4PG  U 300 (-3.3A) 4PG  U 300 (-3.2A)	0.56A	39.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2wpm	COAGULATION FACTOR IXA HEAVY CHAIN (Homo sapiens)	5 / 6	SER S 190 SER S 195 TRP S 215 GLY S 216 GLY S 226	None	0.43A	41.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	2zec	TRYPTASE BETA 2 (Homo sapiens)	6 / 6	SER A 204 SER A 209 VAL A 227 TRP A 229 GLY A 230 GLY A 240	11N  A   1 (-3.5A) 11N  A   1 (-3.3A) None None 11N  A   1 (-3.9A) 11N  A   1 (-3.6A)	0.41A	40.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3f6u	VITAMIN K-DEPENDENT PROTEIN C HEAVY CHAIN (Homo sapiens)	5 / 6	SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0G6  H   1 (-1.8A) None 0G6  H   1 (-4.1A) 0G6  H   1 (-3.8A) 0G6  H   1 ( 3.9A)	0.41A	36.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3gov	MASP-1 (Homo sapiens)	5 / 6	SER B 646 VAL B 666 TRP B 668 GLY B 669 GLY B 679	None	0.43A	35.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3gym	PROSTASIN (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None	0.36A	40.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3r3g	THROMBIN HEAVY CHAIN (Homo sapiens)	5 / 6	SER B 195 VAL B 213 TRP B 215 GLY B 216 GLY B 226	None	0.35A	37.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3w6o	DYNAMIN-1-LIKE PROTEIN (Homo sapiens)	4 / 6	SER A  36 SER A  39 GLY A 149 GLY A  32	GCP  A 801 (-4.0A) MG  A 802 ( 2.0A) GCP  A 801 (-3.6A) None	0.73A	21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	3zjc	GTPASE IMAP FAMILY MEMBER 7 (Homo sapiens)	4 / 6	SER A  19 SER A  22 GLY A  66 GLY A  15	GNP  A1297 (-3.9A) MG  A1296 ( 2.4A) GNP  A1297 ( 4.3A) None	0.68A	18.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4dgj	ENTEROPEPTIDASE CATALYTIC LIGHT CHAIN (Homo sapiens)	4 / 6	SER A 182 SER A 187 GLY A 208 GLY A 218	None	0.67A	37.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 6	SER H 628 VAL H 653 TRP H 655 GLY H 656 GLY H 667	None	0.44A	36.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4igd	MANNAN-BINDING LECTIN SERINE PROTEASE 1 (Homo sapiens)	4 / 6	SER A 646 VAL A 666 TRP A 668 GLY A 679	None None GOL  A 702 (-3.9A) None	0.32A	28.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4iw4	MANNAN-BINDING LECTIN SERINE PROTEASE 3 (Homo sapiens)	5 / 6	SER E 645 VAL E 665 TRP E 667 GLY E 668 GLY E 680	None	0.34A	34.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4k8y	KALLIKREIN-4 (Homo sapiens)	5 / 6	SER A 190 SER A 195 VAL A 213 GLY A 216 GLY A 226	None	0.49A	40.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4kkd	MANNAN-BINDING LECTIN SERINE PROTEASE 1 (Homo sapiens)	4 / 6	VAL A 684 TRP A 686 GLY A 687 GLY A 699	None	0.55A	24.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4r0i	SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN (Homo sapiens)	6 / 6	SER A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	3KM  A 900 (-2.9A) 3KM  A 900 (-3.6A) None None 3KM  A 900 (-3.4A) 3KM  A 900 (-3.2A)	0.24A	40.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4wwy	TRYPSIN-1 (Homo sapiens)	6 / 6	SER A 190 SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	None	0.32A	74.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4ylq	COAGULATION FACTOR VII (Homo sapiens)	6 / 6	SER H 190 SER H 195 VAL H 213 TRP H 215 GLY H 216 GLY H 226	0Z7  H 501 (-2.3A) 0Z7  H 501 (-1.4A) 0Z7  H 501 ( 4.7A) TMA  H 508 ( 3.9A) 0Z7  H 501 (-3.4A) 0Z7  H 501 (-3.0A)	0.37A	40.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5f8z	PLASMA KALLIKREIN LIGHT CHAIN (Homo sapiens)	4 / 6	SER A 195 TRP A 215 GLY A 216 GLY A 226	None	0.45A	41.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5fah	KALLIKREIN-7 (Homo sapiens)	5 / 6	SER A 195 VAL A 213 TRP A 215 GLY A 216 GLY A 226	5VT  A 302 (-4.0A) None None 5VT  A 302 (-3.4A) 5VT  A 302 ( 4.3A)	0.82A	43.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5ms3	KALLIKREIN-8 (Homo sapiens)	4 / 6	SER A 195 TRP A 215 GLY A 216 GLY A 226	None	0.25A	34.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5o32	COMPLEMENT FACTOR I (Homo sapiens)	4 / 6	VAL I 544 TRP I 546 GLY I 547 GLY I 557	None	0.45A	32.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5to3	PROTHROMBIN,THROMBOM ODULIN (Homo sapiens)	4 / 6	SER B 220 VAL B 240 GLY B 243 GLY B 253	0G6  B 501 (-1.3A) None 0G6  B 501 (-3.7A) 0G6  B 501 (-3.6A)	0.25A	27.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5ubm	COMPLEMENT C1S SUBCOMPONENT (Homo sapiens)	6 / 6	SER A 627 SER A 632 VAL A 653 TRP A 655 GLY A 656 GLY A 663	None	0.53A	34.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	6au6	GUANINE NUCLEOTIDE-BINDING PROTEIN G(S) SUBUNIT ALPHA ISOFORMS SHORT (Homo sapiens)	4 / 6	SER A  51 SER A  54 GLY A 226 GLY A  47	GDP  A 401 (-3.4A) MG  A 402 ( 2.1A) None None	0.61A	21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	6b74	COAGULATION FACTOR XII (Homo sapiens)	4 / 6	SER B 195 TRP B 215 GLY B 216 GLY B 226	SO4  B 304 ( 2.5A) None BEN  B 301 (-3.3A) BEN  B 301 (-3.1A)	0.24A	16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	6eoq	DIPEPTIDYL PEPTIDASE 9 (Homo sapiens)	5 / 6	SER A 736 VAL A 643 TRP A 729 GLY A 753 GLY A 733	None	1.40A	14.88